CytomX Therapeutics Price to Book Ratio 2014-2021 | CTMX

Historical price to book ratio values for CytomX Therapeutics (CTMX) over the last 10 years. The current price to book ratio for CytomX Therapeutics as of October 22, 2021 is 2.65.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CytomX Therapeutics Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 5.34 2.66
2021-06-30 6.33 $2.01 3.15
2021-03-31 7.73 $2.25 3.44
2020-12-31 6.55 $1.03 6.35
2020-09-30 6.65 $1.04 6.40
2020-06-30 8.33 $1.27 6.54
2020-03-31 7.67 $1.52 5.05
2019-12-31 8.31 $1.12 7.40
2019-09-30 7.38 $1.81 4.08
2019-06-30 11.22 $2.24 5.02
2019-03-31 10.75 $2.71 3.96
2018-12-31 15.10 $2.90 5.20
2018-09-30 18.50 $3.50 5.28
2018-06-30 22.86 $1.05 21.68
2018-03-31 28.45 $1.28 22.29
2017-12-31 21.11 $1.82 11.62
2017-09-30 18.17 $1.23 14.82
2017-06-30 15.50 $1.42 10.93
2017-03-31 17.27 $2.01 8.59
2016-12-31 10.99 $2.15 5.11
2016-09-30 15.68 $2.46 6.38
2016-06-30 10.22 $2.80 3.65
2016-03-31 12.90 $3.12 4.13
2015-12-31 20.87 $3.50 5.97
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.348B $0.100B
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76